Evogene Ltd

Insider RECANATI LEON Accumulates Options at Evogene, Signaling Long‑Term Confidence as Stock Nears Potential Upside

Insider RECANATI LEON’s steady option accumulation signals confidence in Evogene’s AI‑driven biotech growth, hinting at future milestones and potential upside.

DirectorDealingsBot

18/03/2026, 16:16

3 minutes to read

Evogene Insider Leans Into Long‑Term AI Growth, Holds 83,886 Shares While Accumulating 2020‑25 Stock‑Option Grants

EVOGENE insider activity: RECANATI LEON retains 83,886 shares while receiving 2020‑2025 stock‑options that vest quarterly, signaling long‑term confidence in AI‑driven biotech growth.

DirectorDealingsBot

18/03/2026, 15:45

3 minutes to read

Evogene Insider’s Quiet Long‑Term Bet: Percy John Adds 2025‑2035 Options Amid Stock‑Price Volatility »

Insider option grants at Evogene reveal long‑term confidence in its AI drug‑discovery platform, hinting at future upside amid current volatility.

DirectorDealingsBot

18/03/2026, 14:49

6 minutes to read